AMMAN — The manufacturing company of the Moderna COVID-19
vaccine has submitted all necessary paperwork for the approval of the emergency
use of the vaccine in Jordan, Director of the Jordan Food and Drugs
Administration (JFDA) Nizar Mhiedat said on Saturday.
Mheidat said that the inoculations and vaccines committee is
currently examining the papers, expecting the process to conclude within two
weeks.
More than 1.41 million people have received their first vaccine
shot until last Saturday, while 490,000 people have received the second jab of
the coronavirus vaccine, according to the National Center for Security and
Crisis Management.
FDA has already authorized Sputnik, Pfizer, Sinopharm,
and Astrazeneca vaccines for emergency use.
(window.globalAmlAds = window.globalAmlAds || []).push('admixer_async_509089081')
(window.globalAmlAds = window.globalAmlAds || []).push('admixer_async_552628228')
Read More
Jordan denounces Israeli bombing of area around Damascus' presidential palace
Momani: The Government Remains Committed to Supporting Freedom of the Press and Media
Public Security Directorate Warns of Fire Hazards Ahead of Summer
AMMAN — The manufacturing company of the Moderna COVID-19
vaccine has submitted all necessary paperwork for the approval of the emergency
use of the vaccine in Jordan, Director of the Jordan Food and Drugs
Administration (JFDA) Nizar Mhiedat said on Saturday.
Mheidat said that the inoculations and vaccines committee is
currently examining the papers, expecting the process to conclude within two
weeks.
More than 1.41 million people have received their first vaccine
shot until last Saturday, while 490,000 people have received the second jab of
the coronavirus vaccine, according to the National Center for Security and
Crisis Management.
FDA has already authorized Sputnik, Pfizer, Sinopharm,
and Astrazeneca vaccines for emergency use.
